Dental Care Clinics in Lenoir City, TN Accepting Medicare
8 Dental Care Clinics found. Showing 1 - 8
 Foothills Oral And Maxillofacial Surgery, Pc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 603 Highway 321 N, Bldg. 4, Unit 20, Lenoir City, TN 37771 Phone: 865-986-4582 |
Mabry, Akhrass & Mccary, Dds, Llp Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 603 Highway 321 N, Lenoir City, TN 37771 Phone: 865-986-0842 Fax: 865-986-6459 |
Lenoir City Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 200 N A St, Lenoir City, TN 37771 Phone: 865-986-3514 |
Akhrass Dental Implant And Cosmetic Center Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 603 Highway 321 N Unit 1, Lenoir City, TN 37771 Phone: 865-986-0842 |
Mabry Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 600 Town Creek Rd. East, Lenoir City, TN 37772 Phone: 865-564-6001 Fax: 865-564-6003 |
Town Creek Family Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 875 Highway 321 N, Lenoir City, TN 37771 Phone: 865-816-6327 |
Lenoir City Dental Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 974 Highway 321 N Ste 200, Lenoir City, TN 37771 Phone: 865-440-1526 |
Smoky Mountain Pediatric Dentistry, Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 550 Town Creek Rd E, Suite 101, Lenoir City, TN 37772 Phone: 865-766-4884 |
News Archive
Concert Pharmaceuticals reports results from CTP-499 Phase 2 trial in patients with diabetic kidney disease
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges
Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.
Duane Reade offers H1N1 immunization vaccines for New York residents
Duane Reade, the largest drug store chain in New York City, today announced plans for its H1N1 immunization program as part of the Company's commitment to meet the health and wellness needs of New Yorkers and to be a destination for their flu related needs.
Daxor's signed trial agreement with Pacific Cardiology to provide the BVA-100 instrument
Daxor Corporation, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Pacific Cardiology, LLC of Honolulu, Hawaii. This will provide Pacific Cardiology with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume.
New wearable sensor for non-invasive gout detection
Biomedical scientists are working hard to create more pain-free methods of disease detection and treatment. A simple blood test is highly informative but arouses intense anxiety in many people. Now a new paper published in the journal Nature Biotechnology on November 25, 2019, reports on a new wearable sensor that can be successfully adapted to mass production, is flexible, and can be used to produce readouts of metabolites and nutrients in the blood based on a sweat analysis.
› Verified 6 days ago